Sanofi Board to Support Genzyme Bid of Up to $70 a Share ; report

Sanofi-Aventis CEO Chris Viehbacher has support from his board of directors to offer as much as $70 a share for Genzyme Corp., or about $18.7 billion, three people with knowledge of the situation told Bloomberg News.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.